Suppressive effect of test food on the postprandial blood glucose level

Suppressive effect of test food on the postprandial blood glucose level - Suppressive effect of test food on the postprandial blood glucose level

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000036338

Enrollment

Registered

2019-03-29

Start date

2019-03-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanese subjects

Interventions

Intake of test food, and then intake of placebo after wash out period Intake of placebo, and then intake of test food after wash out period

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: a) Persons who consent to participate in the study, and signed the consent form b) Persons whose fasting blood glucose levels are between 90 and 125 mg/dL c) Persons whose postprandial blood glucose levels increased enough d) Persons who are judged suitable to participate in this trial by physician

Exclusion criteria

Exclusion criteria: a) Persons who have previous medical history of malignant tumor or heart failure or myocardial infarction b) Person who hasn't used a cardiac pacemaker or implantable cardioverter defibrillators c) Patients being treated for at least one of following diseases atrial fibrillation, cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension and other chronic disease d) Persons who routinely take foods for specified health uses, foods with function claims and other functional foods/drinks e) Persons who continually take medicines (including herbal medicine) and supplements f) Persons who are allergic to medicines, or products related to the test material of this trial g) Pregnant women, lactating women, or women who want to get pregnant during the trial period h) Persons who are judged not suitable to participate in this trial by physician

Design outcomes

Primary

Measure	Time frame
Postprandial blood glucose level (Cmax)	—

Secondary

Measure	Time frame
Postprandial insulin level (AUC,Cmax) Postprandial blood glucose levels and insulin levels of 30, 60, 90, and 120 minutes after control food ingestion	—

Countries

Japan

Contacts

Public ContactNaoko SUZUKI

ORTHOMEDICO Inc. R&D Department

nao@orthomedico.jp+81-3-3818-0610

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026